Reproducibility probability in clinical trials

Statistics in Medicine

Volumn 21, Issue 12, 2002, Pages 1727-1742

  Shao, Jun ^a   Chow, Shein Chung ^b  

^a University of Wisconsin Madison   (United States)

^b StatPlus Inc   (United States)

Author keywords

Confidence bound; Generalizability; Power; Sample size; Substantial evidence

Indexed keywords

DRUG;

ARTICLE; BAYES THEOREM; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; EPIDEMIOLOGY; FOOD AND DRUG ADMINISTRATION; LAW; MEDICAL INFORMATION; PROBABILITY; REPRODUCIBILITY; RISK BENEFIT ANALYSIS; SAMPLE SIZE; UNITED STATES;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BAYES THEOREM; DRUG APPROVAL; HUMANS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0037198999     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.1177     Document Type: Article

References (6)

1. Guideline for Format and Content of the Clinical and Statistical Sections of New Drug Applications
2. A comment on replication, p-values and evidence